Drug Shortage Report for DEXILANT
Report ID | 137807 |
Drug Identification Number | 02354969 |
Brand name | DEXILANT |
Common or Proper name | Dexlansoprazole delayed release capsules |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXLANSOPRAZOLE |
Strength(s) | 60MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | NASOGASTRIC ORAL NASOGASTRIC ORAL |
Packaging size | Bottles of 90's |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-04-21 |
Actual start date | 2021-04-21 |
Estimated end date | 2021-08-17 |
Actual end date | 2021-08-17 |
Shortage status | Resolved |
Updated date | 2021-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-08-18 | French | Compare |
v14 | 2021-08-18 | English | Compare |
v13 | 2021-07-30 | French | Compare |
v12 | 2021-07-30 | English | Compare |
v11 | 2021-06-30 | French | Compare |
v10 | 2021-06-30 | English | Compare |
v9 | 2021-06-30 | French | Compare |
v8 | 2021-06-30 | English | Compare |
v7 | 2021-04-22 | English | Compare |
v6 | 2021-04-21 | French | Compare |
v5 | 2021-04-21 | French | Compare |
v4 | 2021-04-21 | English | Compare |
v3 | 2021-04-21 | French | Compare |
v2 | 2021-04-21 | French | Compare |
v1 | 2021-04-21 | English | Compare |
Showing 1 to 15 of 15